Industry News
BIO 2011 biotech profile: Mesoblast
Mesoblast has been making great strides in its stem cell technology over the past several years, and it all paid off with a game changing deal cut with US pharma Cephalon late last year. [ + ]
Top-performing Australian students strive for gold
The 23 talented students chosen to represent Australia at the UNESCO-sanctioned International Science and Mathematical Olympiads have received their team blazers at a ceremony in Parliament House, Canberra.
[ + ]R&D Tax Credit will boost small biotechs
The R&D Tax Credit will give a much needed boost to small cap biotechs, says Karen Sinclair, past president of LESANZ. [ + ]
Controversial biological and gene patent Bill delayed
The Senate has issued an extension until August for the hotly debated Patent Amendment (Human Genes and Biological Materials) Bill. [ + ]
New R&D tax credit will start in July
Australian companies will become more innovative and globally competitive thanks to the new R&D tax incentive.
[ + ]Deadly E. coli strain sequenced by HPA scientists
The deadly E. coli O104 strain found in Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system.
[ + ]R&D Tax Credit (finally) gets the go ahead
Crossbench support has paved the way for the beleaguered R&D Tax Credit to pass the Senate in the next session, coming into effect as of 1 July 2011. [ + ]
QRxPharma to file NDA within two months
After completing a phase III safety trial of analgesic MoxDuo IR QRxPharma (ASX: QRX) is winding up for its New Drug Application within two months time. [ + ]
BIO 2011 special report: The third wave of Australian biotechs
Following the successes of the last six months in Australian biotechnology, the question becomes: who’s next? [ + ]
Molecular diagnostics technology aids management of E. coli crisis
A new xTAG gastrointestinal pathogen panel has been used to triage patients suspected of having an E. coli infection at German Kliniken der Stadt Koln.
[ + ]BIO 2011 special report: Australian biotechnology comes of age
The Australian biotechnology industry has entered a new phase, with several high profile deals demonstrating the sector can truly deliver. Now attention is turning to what comes next. [ + ]
Easy-to-use genome analyser offered
Scientists have developed a genome analyser and browser that allows biologists to analyse and process high-throughput data.
[ + ]Slideshow: Super resolution microscopy
Images from Associate Professor Cynthia Whitchurch and Dr Lynne Turnbull and their DeltaVision|OMX microscope. [ + ]
Feature: Life up close
Associate Professor Cynthia Whitchurch and Dr Lynne Turnbull are helping to reveal new insights into the smallest features of life care of their new super resolution DeltaVision|OMX microscope. [ + ]
